AGX

Business Context and Reporting Period

Company: Argan, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: July 31, 2009
Business Overview: Argan operates through three wholly-owned subsidiaries: Gemma Power Systems (GPS) providing power industry services; Vitarich Laboratories (VLI) manufacturing nutritional products; and Southern Maryland Cable (SMC) providing telecommunications infrastructure services. The company is an accelerated filer and is not a shell company.

Key Financial Metrics

Cash Flow (Six Months Ended July 31, 2009): Net cash used in operating activities was $21.8 million, primarily due to an $11.0 million increase in accounts receivable and an $8.2 million decrease in accounts payable. Net cash used in investing activities was $70,000, and net cash used in financing activities was $702,000.

Material Changes vs. Prior Period

• Revenue Trends: For the three months ended July 31, 2009, consolidated net revenues decreased 13% ($9.6 million) compared to the prior year quarter, driven by a 15% decline in the Power Industry Services segment. However, for the six-month period, revenues increased 4% ($5.1 million) year-over-year.
• Profitability: Net income for the three months ended July 31, 2009, increased significantly to $2.7 million from $806,000 in the prior year quarter. This improvement was largely due to the absence of a $1.9 million impairment loss recorded in the VLI segment during the prior year period.
• Segment Performance:
  • Power Industry Services: Remains the dominant segment, accounting for 91.4% of Q2 2009 revenues. A single customer accounted for approximately 89% of consolidated revenues in Q2 2009.
  • Nutritional Products: Revenues increased 55% in Q2 2009 due to new customer acquisitions, offsetting a 31% decline in sales to existing customers.
  • Telecommunications: Revenues remained relatively flat quarter-over-quarter.
• Expense Reduction: Selling, general, and administrative (SG&A) expenses decreased by $828,000 (21%) in Q2 2009 compared to the prior year, driven by lower legal fees and reduced amortization of intangible assets.

Guidance, Outlook, Risks, and Unusual Items

• Outlook: Management expects profitable operating results for the remainder of the fiscal year based on the scheduled performance of the GPS and GRP (Gemma Renewable Power) contract backlog. However, they caution that the deep recession and credit market disruptions could lead to project delays or cancellations.
• Strategic Acquisition: In August 2009 (subsequent event), Argan signed a non-binding letter of intent to acquire United American Steel Constructors, Inc. (UNAMSCO) for approximately $50 million (cash and stock). UNAMSCO reported $84 million in annual revenues. Financing for the cash portion is being negotiated with the bank.
• Legal Contingencies:
  • Kevin Thomas Litigation: Ongoing lawsuits involving the former owner of VLI regarding compensation and non-compete agreements. Management believes claims are without merit but notes the ultimate resolution could materially affect future results.
  • Tampa Bay Nutraceutical Company: A lawsuit alleging breach of contract and other claims with damages sought in excess of $9 million. Management is vigorously defending the suit but cannot estimate potential damages at this stage.
• Unusual Items: The prior year period included a $1.9 million impairment loss related to VLI goodwill and intangible assets, which is not present in the current period. Additionally, VLI reversed $118,000 of inventory reserves in the current period, reducing cost of revenues.
• Liquidity: The company maintains a $4.25 million revolving line of credit and is in compliance with all financial covenants. Cash balances decreased by $22.6 million during the six-month period due to working capital fluctuations.

Investor Verification Checklist

• Customer Concentration: Verify the stability of the single customer representing ~89% of consolidated revenues in Q2 2009.
• Cash Flow vs. Net Income: Investigate the significant divergence between reported net income ($5.7M) and negative operating cash flow (-$21.8M) for the six-month period, specifically regarding accounts receivable growth.
• Acquisition Financing: Monitor the status of the proposed $50 million UNAMSCO acquisition and the company's ability to secure necessary debt financing.
• Legal Exposure: Track the status of the Tampa Bay Nutraceutical lawsuit ($9M+ claim) and Kevin Thomas litigation for potential material impacts.
• Debt Covenants: Confirm continued compliance with debt covenants (Debt/EBITDA ratios) given the economic environment and potential acquisition leverage.